One Multilocus Genomic Variation Is Responsible for a Severe Charcot-Marie-Tooth Axonal Form.
CNV
Charcot–Marie–Tooth
NGS
diagnosis
multilocus disease
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
15 Dec 2020
15 Dec 2020
Historique:
received:
17
11
2020
revised:
06
12
2020
accepted:
09
12
2020
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
19
12
2020
Statut:
epublish
Résumé
Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited disorders affecting the peripheral nervous system, with a prevalence of 1/2500. So far, mutations in more than 80 genes have been identified causing either demyelinating forms (CMT1) or axonal forms (CMT2). Consequentially, the genotype-phenotype correlation is not always easy to assess. Diagnosis could require multiple analysis before the correct causative mutation is detected. Moreover, it seems that approximately 5% of overall diagnoses for genetic diseases involves multiple genomic loci, although they are often underestimated or underreported. In particular, the combination of multiple variants is rarely described in CMT pathology and often neglected during the diagnostic process. Here, we present the complex genetic analysis of a family including two CMT cases with various severities. Interestingly, next generation sequencing (NGS) associated with Cov'Cop analysis, allowing structural variants (SV) detection, highlighted variations in
Identifiants
pubmed: 33333791
pii: brainsci10120986
doi: 10.3390/brainsci10120986
pmc: PMC7765239
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
FEBS Lett. 2018 Mar;592(5):703-717
pubmed: 29288497
J Neurol. 2011 Jul;258(7):1234-9
pubmed: 21258814
Neurology. 2011 Apr 26;76(17):1524-6
pubmed: 21519004
Nat Genet. 2017 Jul;49(7):1035-1044
pubmed: 28581500
J Med Genet. 2010 Apr;47(4):249-56
pubmed: 19889647
Bioinformatics. 2017 May 15;33(10):1586-1588
pubmed: 28137711
Oncotarget. 2017 Jun 16;8(58):97941-97954
pubmed: 29228664
J Neurol. 2015 Aug;262(8):1899-908
pubmed: 26032230
Brain Res. 2020 Jan 1;1726:146459
pubmed: 31525351
Cell Rep. 2012 Dec 27;2(6):1657-69
pubmed: 23260667
Neuromuscul Disord. 2012 Aug;22(8):735-41
pubmed: 22546700
BMC Med Genet. 2006 Jun 08;7:53
pubmed: 16762064
Brain. 2016 Apr;139(Pt 4):e26
pubmed: 26912637
Neurogenetics. 2005 Sep;6(3):159-63
pubmed: 15947997
Nat Commun. 2018 Feb 13;9(1):651
pubmed: 29440755
Hum Mutat. 2012 Jan;33(1):244-53
pubmed: 22009580
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):195-202
pubmed: 30257968
Hum Mol Genet. 2019 May 15;28(10):1629-1644
pubmed: 30624633
PLoS Comput Biol. 2020 Feb 12;16(2):e1007503
pubmed: 32049956
Am J Hum Genet. 2010 Jan;86(1):77-82
pubmed: 20045102
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Cancer Res. 2018 Oct 15;78(20):5780-5792
pubmed: 30093560
Brain. 2016 Jan;139(Pt 1):62-72
pubmed: 26497905
PLoS Genet. 2011 Dec;7(12):e1002399
pubmed: 22144914
Cold Spring Harb Perspect Med. 2015 Jun 01;5(6):
pubmed: 26033081